Ad
related to: carcinoembryonic ag cea ia non resident schedule
Search results
Results from the WOW.Com Content Network
Carcinoembryonic antigen (CEA) describes a set of highly-related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Consequently, CEA is usually present at very low levels in the blood of healthy adults (about 2–4 ng/mL). [2]
n/a Ensembl ENSG00000124469 n/a UniProt P31997 n/a RefSeq (mRNA) NM_001816 n/a RefSeq (protein) NP_001807 n/a Location (UCSC) Chr 19: 42.58 – 42.6 Mb n/a PubMed search n/a Wikidata View/Edit Human Carcinoembryonic antigen-related cell adhesion molecule 8 (CEACAM8) also known as CD66b (C luster of D ifferentiation 66b), is a member of the carcinoembryonic antigen (CEA) gene family. Its main ...
n/a Ensembl ENSG00000105388 n/a UniProt P06731 n/a RefSeq (mRNA) NM_001291484 NM_001308398 NM_004363 n/a RefSeq (protein) NP_001278413 NP_001295327 NP_004354 n/a Location (UCSC) Chr 19: 41.71 – 41.73 Mb n/a PubMed search n/a Wikidata View/Edit Human Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) also known as CD66e (C luster of D ifferentiation 66e), is a member of the ...
Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) (CEACAM1) also known as CD66a (Cluster of Differentiation 66a), is a human glycoprotein, and a member of the carcinoembryonic antigen (CEA) gene family.
n/a Ensembl ENSG00000086548 n/a UniProt P40199 n/a RefSeq (mRNA) NM_002483 n/a RefSeq (protein) NP_002474 n/a Location (UCSC) Chr 19: 41.75 – 41.77 Mb n/a PubMed search n/a Wikidata View/Edit Human Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) (CEACAM6) also known as CD66c (C luster of D ifferentiation 66c), is a member of the ...
Carcinoembryonic antigen peptide-1 is a nine amino acid peptide fragment of carcinoembryonic antigen (CEA), a protein that is overexpressed in several cancer cell types, including gastrointestinal, breast, and non-small-cell lung. Synonyms: CAP-1; Carcinoembryonic Antigen Peptide-1; Carcinoembryonic Peptide-1; CEA Peptide 1; CEA Peptide 9-mer
Labetuzumab (marketed under the trade name CEA-CIDE) is a humanized IgG1 monoclonal antibody for the treatment of colorectal cancer. [1] It selectively binds to carcinoembryonic cell adhesion molecule 5. [2] Also tried in patients with MTC (medullary thyroid carcinoma) with metastasis. This drug was developed by Immunomedics, Inc.
A second marker, carcinoembryonic antigen (CEA), also produced by medullary thyroid carcinoma, is released into the blood and it is useful as a serum or blood tumor marker. In general, measurement of serum CEA is less sensitive than serum calcitonin for detecting the presence of a tumor, but has less minute to minute variability and is ...
Ad
related to: carcinoembryonic ag cea ia non resident schedule